1) naftopidil tablets
萘哌地尔片
1.
The process monitoring of the dissolution of naftopidil tablets with fiber-optic medicine dissolution/release rate process test system
应用光纤药物溶出仪对萘哌地尔片溶出度的考察
3) naftopidil
萘哌地尔
1.
Determination of naftopidil in human serum by HPLC-fluorescence and study on its pharmacokinetics in healthy volunteers;
高效液相色谱-荧光检测法测定萘哌地尔血药浓度及其在健康人体的药代动力学研究
2.
Evaluation of therapeutic effect of naftopidil in patients with mild to moderate hypertension;
评价萘哌地尔治疗轻中度高血压的临床疗效
3.
The efficacy of naftopidil in treatment of female urethral syndrome;
萘哌地尔治疗女性尿道综合征初探
4) derivative of Naftopidil
萘哌地尔衍生物
1.
Objective To observe the vasodilative effects of YM01, a derivative of Naftopidil(NAF), in spiral strips of rabbit aorta , and evaluate the potential availability of YM01 as new drug.
目的本实验旨在观察萘哌地尔衍生物YM01的扩血管作用,评价其心血管的药理活性。
6) naftopidil ramification B11
萘哌地尔衍生物B11
1.
The effect of naftopidil ramification B11 on the blood pressure and heart rate in rats;
萘哌地尔衍生物B11对大鼠血压及心率的影响
补充资料：萘哌地尔
分子式：C24H28N2O3
分子量：暂无
CAS号：57149-07-2
性质：暂无
制备方法：暂无
用途：血管扩张药。
分子量：暂无
CAS号：57149-07-2
性质：暂无
制备方法：暂无
用途：血管扩张药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条